Pfizer to Buy Seagen in $43 Billion Deal
By Colin Kellaher
Pfizer Inc on Monday said it has agreed to buy biotech company Seagen Inc for $43 billion in a move to bolster its cancer program.
The New York-based drugmaker said it would pay $229…